Literature DB >> 9703293

Incidence rates of classical Kaposi's sarcoma and multiple myeloma do not correlate.

H Hjalgrim1, M Frisch, M Melbye.   

Abstract

We compared population-based incidence rates for classical Kaposi's sarcoma and multiple myeloma. Neither for men (Spearman's rank correlation coefficient (r) = 0.01, P = 0.97, 13 pairs) nor for women (r = 0.24, P = 0.42, 13 pairs) did the incidences of the two conditions correlate. This absence of correlation does not support the hypothesis that Kaposi's sarcoma and multiple myeloma share a common aetiology, such as HHV-8.

Entities:  

Mesh：

Year:  1998        PMID： 9703293      PMCID： PMC2063027          DOI： 10.1038/bjc.1998.509

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  24 in total

1.  Herpes-like DNA sequences, AIDS-related tumors, and Castleman's disease.

Authors:  N Dupin; I Gorin; J Deleuze; H Agut; J M Huraux; J P Escande
Journal:  N Engl J Med       Date:  1995-09-21       Impact factor: 91.245

2.  Kaposi's sarcoma in the Swiss Canton of Vaud, 1974-1990.

Authors:  F Levi; S Franceschi; C La Vecchia
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

3.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

4.  Risk of other cancers following Kaposi's sarcoma: relation to acquired immunodeficiency syndrome.

Authors:  R J Biggar; R E Curtis; T R Cote; C S Rabkin; M Melbye
Journal:  Am J Epidemiol       Date:  1994-02-15       Impact factor: 4.897

5.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

6.  Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-81.

Authors:  R J Biggar; J Horm; J F Fraumeni; M H Greene; J J Goedert
Journal:  J Natl Cancer Inst       Date:  1984-07       Impact factor: 13.506

7.  Distribution of Kaposi's sarcoma herpesvirus sequences among lymphoid malignancies in Italy and Spain.

Authors:  C Pastore; A Gloghini; G Volpe; J Nomdedeu; E Leonardo; U Mazza; G Saglio; A Carbone; G Gaidano
Journal:  Br J Haematol       Date:  1995-12       Impact factor: 6.998

8.  Epidemiological characteristics of Kaposi's sarcoma prior to the AIDS epidemic.

Authors:  J M Kaldor; M Coates; L Vettom; R Taylor
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

9.  High incidence of classical Kaposi's sarcoma in Iceland and the Faroe Islands.

Authors:  H Hjalgrim; H Tulinius; J Dalberg; S Hardarson; M Frisch; M Melbye
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

10.  Kaposi's sarcoma in Italy before and after the AIDS epidemic.

Authors:  M Geddes; S Franceschi; A Barchielli; F Falcini; S Carli; G Cocconi; E Conti; P Crosignani; L Gafà; L Giarelli
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640
View more
  3 in total

1.  CD68+/CD83+/CD1a- dendritic cell subsets from patients with multiple myeloma are not infected with human herpesvirus 8.

Authors:  T Rasmussen; I M Dahl; L Jensen; H E Johnsen
Journal:  Med Oncol       Date:  2000-08       Impact factor: 3.064

Review 2.  Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Authors:  Dharam V Ablashi; Louise G Chatlynne; James E Whitman; Ethel Cesarman
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

Review 3.  Laboratory diagnosis of human herpesvirus 8 infection in humans.

Authors:  R Tedeschi; J Dillner; P De Paoli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-12-11       Impact factor: 5.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.